News Releases

Select year
Categories

Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025

Apr 29, 2025 | Corporate | Financial

Read more

Myriad Genetics Announces Inducement Awards

Apr 08, 2025 | Corporate | Financial

Read more

Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer

Apr 07, 2025 | Corporate

Read more

Myriad Genetics Announces Senior Leadership Transition

Feb 24, 2025 | Corporate | Financial

Read more

Myriad Genetics Reports Fourth Quarter and Full-Year 2024 Financial Results; Full-year 2024 revenue of $838 million grew 11% year-over-year, the second consecutive year of double-digit revenue growth

Feb 24, 2025 | Corporate | Financial

Read more

Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio

Feb 24, 2025 | Corporate | Pipeline | Products

Read more

Myriad Genetics Included in Forbes America’s Best Employers 2025 List

Feb 19, 2025 | Corporate

Read more

Myriad Genetics to Release Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025

Feb 18, 2025 | Corporate | Financial

Read more

Myriad Genetics Announces Two New Patents Granted for its Molecular Residual Disease (MRD) Assay

Feb 05, 2025 | Corporate | Pipeline

Read more

Myriad Genetics Announces Hereditary Cancer Risk Assessment Program Study Published in Obstetrics & Gynecology

Jan 21, 2025 | Products | Corporate

Read more

Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2024 Financial Results and Introduces Full Year 2025 Financial Guidance

Jan 15, 2025 | Financial | Corporate

Read more

Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

Jan 09, 2025 | Products | Corporate

Read more

Myriad Genetics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Jan 08, 2025 | Corporate | Financial

Read more

MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay

Jan 07, 2025 | Products | Corporate

Read more

Myriad Genetics Issues Quality, Innovation, and Corporate Responsibility Report

Jan 06, 2025 | Corporate

Read more